Exscientia Balance Sheet Health
Financial Health criteria checks 5/6
Exscientia has a total shareholder equity of £355.7M and total debt of £306.0K, which brings its debt-to-equity ratio to 0.09%. Its total assets and total liabilities are £510.7M and £155.0M respectively.
Key information
0.09%
Debt to equity ratio
UK£306.00k
Debt
| Interest coverage ratio | n/a |
| Cash | UK£363.05m |
| Equity | UK£355.73m |
| Total liabilities | UK£155.00m |
| Total assets | UK£510.72m |
Recent financial health updates
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11
We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Recent updates
Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Feb 26Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 12New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)
Aug 31We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher
Jul 21Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts
Aug 31Exscientia: Using AI To Power Drug Development
Aug 15Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline
Apr 12Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts
Jan 09Financial Position Analysis
Short Term Liabilities: EXAI's short term assets (£404.9M) exceed its short term liabilities (£65.1M).
Long Term Liabilities: EXAI's short term assets (£404.9M) exceed its long term liabilities (£89.9M).
Debt to Equity History and Analysis
Debt Level: EXAI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if EXAI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXAI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EXAI has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 78% each year.